nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—prostate cancer	0.471	0.769	CbGaD
Pseudoephedrine—ADRB2—prostate cancer	0.141	0.23	CbGaD
Pseudoephedrine—NFATC1—prostate gland—prostate cancer	0.00656	0.14	CbGeAlD
Pseudoephedrine—IL2—epithelium—prostate cancer	0.00441	0.0941	CbGeAlD
Pseudoephedrine—IL2—renal system—prostate cancer	0.00409	0.0873	CbGeAlD
Pseudoephedrine—NFATC1—bone marrow—prostate cancer	0.00338	0.0722	CbGeAlD
Pseudoephedrine—CYP2D6—Bicalutamide—prostate cancer	0.00333	0.504	CbGbCtD
Pseudoephedrine—IL2—bone marrow—prostate cancer	0.00309	0.066	CbGeAlD
Pseudoephedrine—NFATC1—testis—prostate cancer	0.00289	0.0617	CbGeAlD
Pseudoephedrine—CYP2D6—Abiraterone—prostate cancer	0.00276	0.418	CbGbCtD
Pseudoephedrine—NFATC1—lymph node—prostate cancer	0.00209	0.0447	CbGeAlD
Pseudoephedrine—TNF—lymph node—prostate cancer	0.002	0.0427	CbGeAlD
Pseudoephedrine—CYP2D6—urine—prostate cancer	0.00195	0.0417	CbGeAlD
Pseudoephedrine—IL2—lymph node—prostate cancer	0.00192	0.0409	CbGeAlD
Pseudoephedrine—ADRB1—prostate gland—prostate cancer	0.0015	0.0321	CbGeAlD
Pseudoephedrine—ADRA1A—prostate gland—prostate cancer	0.00119	0.0254	CbGeAlD
Pseudoephedrine—MAOA—prostate gland—prostate cancer	0.00118	0.0252	CbGeAlD
Pseudoephedrine—MAOA—seminal vesicle—prostate cancer	0.000996	0.0213	CbGeAlD
Pseudoephedrine—ADRA2A—prostate gland—prostate cancer	0.000904	0.0193	CbGeAlD
Pseudoephedrine—ADRA1A—epithelium—prostate cancer	0.000873	0.0187	CbGeAlD
Pseudoephedrine—ADRA1A—renal system—prostate cancer	0.00081	0.0173	CbGeAlD
Pseudoephedrine—MAOA—renal system—prostate cancer	0.000803	0.0171	CbGeAlD
Pseudoephedrine—MAOA—urethra—prostate cancer	0.000789	0.0168	CbGeAlD
Pseudoephedrine—ADRA2A—seminal vesicle—prostate cancer	0.000764	0.0163	CbGeAlD
Pseudoephedrine—SLC6A3—testis—prostate cancer	0.000698	0.0149	CbGeAlD
Pseudoephedrine—ADRA2A—urethra—prostate cancer	0.000605	0.0129	CbGeAlD
Pseudoephedrine—SLC6A2—testis—prostate cancer	0.000563	0.012	CbGeAlD
Pseudoephedrine—MAOA—testis—prostate cancer	0.000519	0.0111	CbGeAlD
Pseudoephedrine—CYP2D6—Doxorubicin—prostate cancer	0.000511	0.0773	CbGbCtD
Pseudoephedrine—Ephedrine—ACHE—prostate cancer	0.00049	0.142	CrCbGaD
Pseudoephedrine—CYP2D6—renal system—prostate cancer	0.000477	0.0102	CbGeAlD
Pseudoephedrine—SLC6A2—lymph node—prostate cancer	0.000408	0.00872	CbGeAlD
Pseudoephedrine—ADRA2A—testis—prostate cancer	0.000398	0.0085	CbGeAlD
Pseudoephedrine—Etomidate—CYP19A1—prostate cancer	0.000381	0.111	CrCbGaD
Pseudoephedrine—MAOA—lymph node—prostate cancer	0.000376	0.00803	CbGeAlD
Pseudoephedrine—Amphetamine—SLC22A3—prostate cancer	0.000333	0.0967	CrCbGaD
Pseudoephedrine—Methamphetamine—SLC22A3—prostate cancer	0.000309	0.0896	CrCbGaD
Pseudoephedrine—CYP2D6—testis—prostate cancer	0.000308	0.00659	CbGeAlD
Pseudoephedrine—ADRA2A—lymph node—prostate cancer	0.000289	0.00616	CbGeAlD
Pseudoephedrine—Urinary retention—Capecitabine—prostate cancer	0.000258	0.00195	CcSEcCtD
Pseudoephedrine—Anorexia—Goserelin—prostate cancer	0.000257	0.00194	CcSEcCtD
Pseudoephedrine—Tension—Estradiol—prostate cancer	0.000257	0.00194	CcSEcCtD
Pseudoephedrine—Dizziness—Bicalutamide—prostate cancer	0.000256	0.00193	CcSEcCtD
Pseudoephedrine—Anorexia—Conjugated Estrogens—prostate cancer	0.000255	0.00192	CcSEcCtD
Pseudoephedrine—Nervousness—Estradiol—prostate cancer	0.000254	0.00192	CcSEcCtD
Pseudoephedrine—Muscle spasms—Estradiol—prostate cancer	0.000252	0.0019	CcSEcCtD
Pseudoephedrine—Arrhythmia—Mitoxantrone—prostate cancer	0.00025	0.00189	CcSEcCtD
Pseudoephedrine—Ephedrine—ADRB2—prostate cancer	0.000248	0.072	CrCbGaD
Pseudoephedrine—Vomiting—Bicalutamide—prostate cancer	0.000246	0.00186	CcSEcCtD
Pseudoephedrine—Tremor—Estradiol—prostate cancer	0.000245	0.00185	CcSEcCtD
Pseudoephedrine—Rash—Bicalutamide—prostate cancer	0.000244	0.00184	CcSEcCtD
Pseudoephedrine—Dermatitis—Bicalutamide—prostate cancer	0.000244	0.00184	CcSEcCtD
Pseudoephedrine—Insomnia—Goserelin—prostate cancer	0.000244	0.00184	CcSEcCtD
Pseudoephedrine—Headache—Bicalutamide—prostate cancer	0.000243	0.00183	CcSEcCtD
Pseudoephedrine—Insomnia—Conjugated Estrogens—prostate cancer	0.000242	0.00182	CcSEcCtD
Pseudoephedrine—Agitation—Estradiol—prostate cancer	0.000241	0.00182	CcSEcCtD
Pseudoephedrine—Dyspnoea—Goserelin—prostate cancer	0.00024	0.00181	CcSEcCtD
Pseudoephedrine—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000238	0.0018	CcSEcCtD
Pseudoephedrine—Dyspepsia—Goserelin—prostate cancer	0.000237	0.00179	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Prednisone—prostate cancer	0.000236	0.00178	CcSEcCtD
Pseudoephedrine—Angina pectoris—Docetaxel—prostate cancer	0.000236	0.00178	CcSEcCtD
Pseudoephedrine—Vertigo—Estradiol—prostate cancer	0.000235	0.00178	CcSEcCtD
Pseudoephedrine—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000235	0.00177	CcSEcCtD
Pseudoephedrine—Asthenia—Ethinyl Estradiol—prostate cancer	0.000235	0.00177	CcSEcCtD
Pseudoephedrine—Decreased appetite—Goserelin—prostate cancer	0.000234	0.00177	CcSEcCtD
Pseudoephedrine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000232	0.00175	CcSEcCtD
Pseudoephedrine—Palpitations—Estradiol—prostate cancer	0.000231	0.00175	CcSEcCtD
Pseudoephedrine—Irritability—Prednisone—prostate cancer	0.000231	0.00174	CcSEcCtD
Pseudoephedrine—Pain—Goserelin—prostate cancer	0.000231	0.00174	CcSEcCtD
Pseudoephedrine—Nausea—Bicalutamide—prostate cancer	0.00023	0.00174	CcSEcCtD
Pseudoephedrine—Pain—Conjugated Estrogens—prostate cancer	0.000228	0.00172	CcSEcCtD
Pseudoephedrine—Angina pectoris—Capecitabine—prostate cancer	0.000228	0.00172	CcSEcCtD
Pseudoephedrine—Hypertension—Estradiol—prostate cancer	0.000226	0.00171	CcSEcCtD
Pseudoephedrine—Selegiline—CYP2A6—prostate cancer	0.000224	0.0652	CrCbGaD
Pseudoephedrine—Chest pain—Estradiol—prostate cancer	0.000223	0.00168	CcSEcCtD
Pseudoephedrine—Phenylpropanolamine—ADRB2—prostate cancer	0.000222	0.0646	CrCbGaD
Pseudoephedrine—Anxiety—Estradiol—prostate cancer	0.000222	0.00168	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Goserelin—prostate cancer	0.000222	0.00168	CcSEcCtD
Pseudoephedrine—Dysuria—Capecitabine—prostate cancer	0.000219	0.00165	CcSEcCtD
Pseudoephedrine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000217	0.00163	CcSEcCtD
Pseudoephedrine—Confusional state—Estradiol—prostate cancer	0.000215	0.00163	CcSEcCtD
Pseudoephedrine—Body temperature increased—Goserelin—prostate cancer	0.000213	0.00161	CcSEcCtD
Pseudoephedrine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000211	0.00159	CcSEcCtD
Pseudoephedrine—Hypertension—Mitoxantrone—prostate cancer	0.000211	0.00159	CcSEcCtD
Pseudoephedrine—Tachycardia—Estradiol—prostate cancer	0.000209	0.00157	CcSEcCtD
Pseudoephedrine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000208	0.00157	CcSEcCtD
Pseudoephedrine—Chest pain—Mitoxantrone—prostate cancer	0.000208	0.00157	CcSEcCtD
Pseudoephedrine—Anxiety—Mitoxantrone—prostate cancer	0.000207	0.00156	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Estradiol—prostate cancer	0.000207	0.00156	CcSEcCtD
Pseudoephedrine—Rash—Ethinyl Estradiol—prostate cancer	0.000207	0.00156	CcSEcCtD
Pseudoephedrine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000206	0.00156	CcSEcCtD
Pseudoephedrine—Headache—Ethinyl Estradiol—prostate cancer	0.000205	0.00155	CcSEcCtD
Pseudoephedrine—Confusional state—Mitoxantrone—prostate cancer	0.000201	0.00151	CcSEcCtD
Pseudoephedrine—Muscle spasms—Etoposide—prostate cancer	0.000195	0.00147	CcSEcCtD
Pseudoephedrine—Nausea—Ethinyl Estradiol—prostate cancer	0.000195	0.00147	CcSEcCtD
Pseudoephedrine—Tachycardia—Mitoxantrone—prostate cancer	0.000194	0.00147	CcSEcCtD
Pseudoephedrine—Asthenia—Goserelin—prostate cancer	0.000193	0.00146	CcSEcCtD
Pseudoephedrine—Insomnia—Estradiol—prostate cancer	0.000193	0.00146	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000192	0.00145	CcSEcCtD
Pseudoephedrine—Asthenia—Conjugated Estrogens—prostate cancer	0.000192	0.00145	CcSEcCtD
Pseudoephedrine—Bradycardia—Capecitabine—prostate cancer	0.000191	0.00144	CcSEcCtD
Pseudoephedrine—Dyspnoea—Estradiol—prostate cancer	0.000191	0.00144	CcSEcCtD
Pseudoephedrine—Anorexia—Mitoxantrone—prostate cancer	0.00019	0.00143	CcSEcCtD
Pseudoephedrine—Dyspepsia—Estradiol—prostate cancer	0.000188	0.00142	CcSEcCtD
Pseudoephedrine—Amphetamine—CYP2A6—prostate cancer	0.000186	0.0542	CrCbGaD
Pseudoephedrine—Decreased appetite—Estradiol—prostate cancer	0.000186	0.0014	CcSEcCtD
Pseudoephedrine—Pain—Estradiol—prostate cancer	0.000183	0.00138	CcSEcCtD
Pseudoephedrine—Vertigo—Etoposide—prostate cancer	0.000182	0.00138	CcSEcCtD
Pseudoephedrine—Dizziness—Goserelin—prostate cancer	0.000178	0.00135	CcSEcCtD
Pseudoephedrine—Dyspnoea—Mitoxantrone—prostate cancer	0.000178	0.00134	CcSEcCtD
Pseudoephedrine—Dizziness—Conjugated Estrogens—prostate cancer	0.000177	0.00133	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Estradiol—prostate cancer	0.000176	0.00133	CcSEcCtD
Pseudoephedrine—Dyspepsia—Mitoxantrone—prostate cancer	0.000175	0.00132	CcSEcCtD
Pseudoephedrine—Hypertension—Etoposide—prostate cancer	0.000175	0.00132	CcSEcCtD
Pseudoephedrine—Decreased appetite—Mitoxantrone—prostate cancer	0.000173	0.00131	CcSEcCtD
Pseudoephedrine—Arrhythmia—Docetaxel—prostate cancer	0.000173	0.00131	CcSEcCtD
Pseudoephedrine—Chest pain—Etoposide—prostate cancer	0.000173	0.0013	CcSEcCtD
Pseudoephedrine—Vomiting—Goserelin—prostate cancer	0.000171	0.00129	CcSEcCtD
Pseudoephedrine—Pain—Mitoxantrone—prostate cancer	0.00017	0.00128	CcSEcCtD
Pseudoephedrine—Bradycardia—Prednisone—prostate cancer	0.00017	0.00128	CcSEcCtD
Pseudoephedrine—Rash—Goserelin—prostate cancer	0.00017	0.00128	CcSEcCtD
Pseudoephedrine—Dermatitis—Goserelin—prostate cancer	0.00017	0.00128	CcSEcCtD
Pseudoephedrine—Vomiting—Conjugated Estrogens—prostate cancer	0.00017	0.00128	CcSEcCtD
Pseudoephedrine—Body temperature increased—Estradiol—prostate cancer	0.000169	0.00127	CcSEcCtD
Pseudoephedrine—Headache—Goserelin—prostate cancer	0.000169	0.00127	CcSEcCtD
Pseudoephedrine—Rash—Conjugated Estrogens—prostate cancer	0.000168	0.00127	CcSEcCtD
Pseudoephedrine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000168	0.00127	CcSEcCtD
Pseudoephedrine—Arrhythmia—Capecitabine—prostate cancer	0.000168	0.00126	CcSEcCtD
Pseudoephedrine—Headache—Conjugated Estrogens—prostate cancer	0.000167	0.00126	CcSEcCtD
Pseudoephedrine—Confusional state—Etoposide—prostate cancer	0.000167	0.00126	CcSEcCtD
Pseudoephedrine—Hallucination—Prednisone—prostate cancer	0.000166	0.00125	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP2E1—prostate cancer	0.000166	0.0483	CrCbGaD
Pseudoephedrine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000164	0.00124	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP1A1—prostate cancer	0.000164	0.0476	CrCbGaD
Pseudoephedrine—Muscle spasms—Docetaxel—prostate cancer	0.000162	0.00122	CcSEcCtD
Pseudoephedrine—Tachycardia—Etoposide—prostate cancer	0.000162	0.00122	CcSEcCtD
Pseudoephedrine—Nausea—Goserelin—prostate cancer	0.00016	0.00121	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Etoposide—prostate cancer	0.00016	0.00121	CcSEcCtD
Pseudoephedrine—Selegiline—CYP2E1—prostate cancer	0.000159	0.0463	CrCbGaD
Pseudoephedrine—Angina pectoris—Epirubicin—prostate cancer	0.000159	0.0012	CcSEcCtD
Pseudoephedrine—Nausea—Conjugated Estrogens—prostate cancer	0.000159	0.0012	CcSEcCtD
Pseudoephedrine—Anorexia—Etoposide—prostate cancer	0.000158	0.00119	CcSEcCtD
Pseudoephedrine—Selegiline—CYP2C19—prostate cancer	0.000158	0.0459	CrCbGaD
Pseudoephedrine—Body temperature increased—Mitoxantrone—prostate cancer	0.000157	0.00119	CcSEcCtD
Pseudoephedrine—Muscle spasms—Capecitabine—prostate cancer	0.000157	0.00118	CcSEcCtD
Pseudoephedrine—Asthenia—Estradiol—prostate cancer	0.000153	0.00116	CcSEcCtD
Pseudoephedrine—Tremor—Capecitabine—prostate cancer	0.000153	0.00115	CcSEcCtD
Pseudoephedrine—Dysuria—Epirubicin—prostate cancer	0.000153	0.00115	CcSEcCtD
Pseudoephedrine—Arrhythmia—Prednisone—prostate cancer	0.000149	0.00113	CcSEcCtD
Pseudoephedrine—Palpitations—Docetaxel—prostate cancer	0.000149	0.00112	CcSEcCtD
Pseudoephedrine—Dyspnoea—Etoposide—prostate cancer	0.000148	0.00111	CcSEcCtD
Pseudoephedrine—Angina pectoris—Doxorubicin—prostate cancer	0.000147	0.00111	CcSEcCtD
Pseudoephedrine—Vertigo—Capecitabine—prostate cancer	0.000147	0.00111	CcSEcCtD
Pseudoephedrine—Hypertension—Docetaxel—prostate cancer	0.000146	0.0011	CcSEcCtD
Pseudoephedrine—Palpitations—Capecitabine—prostate cancer	0.000144	0.00109	CcSEcCtD
Pseudoephedrine—Decreased appetite—Etoposide—prostate cancer	0.000144	0.00109	CcSEcCtD
Pseudoephedrine—Chest pain—Docetaxel—prostate cancer	0.000144	0.00108	CcSEcCtD
Pseudoephedrine—Asthenia—Mitoxantrone—prostate cancer	0.000143	0.00108	CcSEcCtD
Pseudoephedrine—Pain—Etoposide—prostate cancer	0.000142	0.00107	CcSEcCtD
Pseudoephedrine—Dizziness—Estradiol—prostate cancer	0.000141	0.00107	CcSEcCtD
Pseudoephedrine—Dysuria—Doxorubicin—prostate cancer	0.000141	0.00107	CcSEcCtD
Pseudoephedrine—Hypertension—Capecitabine—prostate cancer	0.000141	0.00106	CcSEcCtD
Pseudoephedrine—Sweating—Epirubicin—prostate cancer	0.00014	0.00105	CcSEcCtD
Pseudoephedrine—Chest pain—Capecitabine—prostate cancer	0.000139	0.00105	CcSEcCtD
Pseudoephedrine—Confusional state—Docetaxel—prostate cancer	0.000139	0.00105	CcSEcCtD
Pseudoephedrine—Anxiety—Capecitabine—prostate cancer	0.000139	0.00105	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Etoposide—prostate cancer	0.000136	0.00103	CcSEcCtD
Pseudoephedrine—Vomiting—Estradiol—prostate cancer	0.000136	0.00103	CcSEcCtD
Pseudoephedrine—Rash—Estradiol—prostate cancer	0.000135	0.00102	CcSEcCtD
Pseudoephedrine—Dermatitis—Estradiol—prostate cancer	0.000135	0.00102	CcSEcCtD
Pseudoephedrine—Confusional state—Capecitabine—prostate cancer	0.000134	0.00101	CcSEcCtD
Pseudoephedrine—Tachycardia—Docetaxel—prostate cancer	0.000134	0.00101	CcSEcCtD
Pseudoephedrine—Headache—Estradiol—prostate cancer	0.000134	0.00101	CcSEcCtD
Pseudoephedrine—Agitation—Prednisone—prostate cancer	0.000134	0.00101	CcSEcCtD
Pseudoephedrine—Bradycardia—Epirubicin—prostate cancer	0.000133	0.001	CcSEcCtD
Pseudoephedrine—Anorexia—Docetaxel—prostate cancer	0.000131	0.00099	CcSEcCtD
Pseudoephedrine—Body temperature increased—Etoposide—prostate cancer	0.000131	0.000988	CcSEcCtD
Pseudoephedrine—Vertigo—Prednisone—prostate cancer	0.000131	0.000986	CcSEcCtD
Pseudoephedrine—Tachycardia—Capecitabine—prostate cancer	0.00013	0.000981	CcSEcCtD
Pseudoephedrine—Sweating—Doxorubicin—prostate cancer	0.000129	0.000974	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Capecitabine—prostate cancer	0.000129	0.000972	CcSEcCtD
Pseudoephedrine—Anorexia—Capecitabine—prostate cancer	0.000127	0.000959	CcSEcCtD
Pseudoephedrine—Nausea—Estradiol—prostate cancer	0.000127	0.000958	CcSEcCtD
Pseudoephedrine—Vomiting—Mitoxantrone—prostate cancer	0.000127	0.000955	CcSEcCtD
Pseudoephedrine—Hypertension—Prednisone—prostate cancer	0.000126	0.000948	CcSEcCtD
Pseudoephedrine—Rash—Mitoxantrone—prostate cancer	0.000126	0.000947	CcSEcCtD
Pseudoephedrine—Dermatitis—Mitoxantrone—prostate cancer	0.000125	0.000946	CcSEcCtD
Pseudoephedrine—Headache—Mitoxantrone—prostate cancer	0.000125	0.000941	CcSEcCtD
Pseudoephedrine—Insomnia—Docetaxel—prostate cancer	0.000124	0.000939	CcSEcCtD
Pseudoephedrine—Anxiety—Prednisone—prostate cancer	0.000123	0.000931	CcSEcCtD
Pseudoephedrine—Bradycardia—Doxorubicin—prostate cancer	0.000123	0.000929	CcSEcCtD
Pseudoephedrine—Dyspnoea—Docetaxel—prostate cancer	0.000123	0.000926	CcSEcCtD
Pseudoephedrine—Dyspepsia—Docetaxel—prostate cancer	0.000121	0.000914	CcSEcCtD
Pseudoephedrine—Insomnia—Capecitabine—prostate cancer	0.000121	0.000909	CcSEcCtD
Pseudoephedrine—Decreased appetite—Docetaxel—prostate cancer	0.00012	0.000903	CcSEcCtD
Pseudoephedrine—Atomoxetine—CYP2C19—prostate cancer	0.00012	0.0347	CrCbGaD
Pseudoephedrine—Asthenia—Etoposide—prostate cancer	0.000119	0.000897	CcSEcCtD
Pseudoephedrine—Dyspnoea—Capecitabine—prostate cancer	0.000119	0.000897	CcSEcCtD
Pseudoephedrine—Nausea—Mitoxantrone—prostate cancer	0.000118	0.000892	CcSEcCtD
Pseudoephedrine—Pain—Docetaxel—prostate cancer	0.000118	0.000888	CcSEcCtD
Pseudoephedrine—Dyspepsia—Capecitabine—prostate cancer	0.000117	0.000885	CcSEcCtD
Pseudoephedrine—Arrhythmia—Epirubicin—prostate cancer	0.000117	0.000881	CcSEcCtD
Pseudoephedrine—Tachycardia—Prednisone—prostate cancer	0.000116	0.000874	CcSEcCtD
Pseudoephedrine—Decreased appetite—Capecitabine—prostate cancer	0.000116	0.000874	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Prednisone—prostate cancer	0.000115	0.000866	CcSEcCtD
Pseudoephedrine—Pain—Capecitabine—prostate cancer	0.000114	0.00086	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Docetaxel—prostate cancer	0.000113	0.000856	CcSEcCtD
Pseudoephedrine—Anorexia—Prednisone—prostate cancer	0.000113	0.000854	CcSEcCtD
Pseudoephedrine—Tension—Epirubicin—prostate cancer	0.000112	0.000842	CcSEcCtD
Pseudoephedrine—Nervousness—Epirubicin—prostate cancer	0.00011	0.000834	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Capecitabine—prostate cancer	0.00011	0.000829	CcSEcCtD
Pseudoephedrine—Dizziness—Etoposide—prostate cancer	0.00011	0.000826	CcSEcCtD
Pseudoephedrine—Muscle spasms—Epirubicin—prostate cancer	0.000109	0.000825	CcSEcCtD
Pseudoephedrine—Body temperature increased—Docetaxel—prostate cancer	0.000109	0.000821	CcSEcCtD
Pseudoephedrine—Arrhythmia—Doxorubicin—prostate cancer	0.000108	0.000815	CcSEcCtD
Pseudoephedrine—Insomnia—Prednisone—prostate cancer	0.000107	0.00081	CcSEcCtD
Pseudoephedrine—Body temperature increased—Capecitabine—prostate cancer	0.000105	0.000795	CcSEcCtD
Pseudoephedrine—Vomiting—Etoposide—prostate cancer	0.000105	0.000795	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP3A4—prostate cancer	0.000105	0.0304	CrCbGaD
Pseudoephedrine—Agitation—Epirubicin—prostate cancer	0.000105	0.000789	CcSEcCtD
Pseudoephedrine—Dyspepsia—Prednisone—prostate cancer	0.000104	0.000788	CcSEcCtD
Pseudoephedrine—Rash—Etoposide—prostate cancer	0.000104	0.000788	CcSEcCtD
Pseudoephedrine—Dermatitis—Etoposide—prostate cancer	0.000104	0.000787	CcSEcCtD
Pseudoephedrine—Headache—Etoposide—prostate cancer	0.000104	0.000783	CcSEcCtD
Pseudoephedrine—Tension—Doxorubicin—prostate cancer	0.000103	0.000779	CcSEcCtD
Pseudoephedrine—Decreased appetite—Prednisone—prostate cancer	0.000103	0.000779	CcSEcCtD
Pseudoephedrine—Nervousness—Doxorubicin—prostate cancer	0.000102	0.000771	CcSEcCtD
Pseudoephedrine—Vertigo—Epirubicin—prostate cancer	0.000102	0.000771	CcSEcCtD
Pseudoephedrine—Muscle spasms—Doxorubicin—prostate cancer	0.000101	0.000764	CcSEcCtD
Pseudoephedrine—Palpitations—Epirubicin—prostate cancer	0.000101	0.000759	CcSEcCtD
Pseudoephedrine—Selegiline—CYP3A4—prostate cancer	0.0001	0.0292	CrCbGaD
Pseudoephedrine—Asthenia—Docetaxel—prostate cancer	9.88e-05	0.000745	CcSEcCtD
Pseudoephedrine—Nausea—Etoposide—prostate cancer	9.84e-05	0.000742	CcSEcCtD
Pseudoephedrine—Hypertension—Epirubicin—prostate cancer	9.82e-05	0.000741	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Prednisone—prostate cancer	9.78e-05	0.000738	CcSEcCtD
Pseudoephedrine—Chest pain—Epirubicin—prostate cancer	9.69e-05	0.000731	CcSEcCtD
Pseudoephedrine—Agitation—Doxorubicin—prostate cancer	9.67e-05	0.00073	CcSEcCtD
Pseudoephedrine—Anxiety—Epirubicin—prostate cancer	9.65e-05	0.000728	CcSEcCtD
Pseudoephedrine—Asthenia—Capecitabine—prostate cancer	9.56e-05	0.000721	CcSEcCtD
Pseudoephedrine—Vertigo—Doxorubicin—prostate cancer	9.46e-05	0.000714	CcSEcCtD
Pseudoephedrine—Body temperature increased—Prednisone—prostate cancer	9.38e-05	0.000708	CcSEcCtD
Pseudoephedrine—Confusional state—Epirubicin—prostate cancer	9.36e-05	0.000706	CcSEcCtD
Pseudoephedrine—Palpitations—Doxorubicin—prostate cancer	9.3e-05	0.000702	CcSEcCtD
Pseudoephedrine—Dizziness—Docetaxel—prostate cancer	9.1e-05	0.000687	CcSEcCtD
Pseudoephedrine—Hypertension—Doxorubicin—prostate cancer	9.09e-05	0.000686	CcSEcCtD
Pseudoephedrine—Tachycardia—Epirubicin—prostate cancer	9.06e-05	0.000684	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Epirubicin—prostate cancer	8.98e-05	0.000677	CcSEcCtD
Pseudoephedrine—Chest pain—Doxorubicin—prostate cancer	8.96e-05	0.000676	CcSEcCtD
Pseudoephedrine—Anxiety—Doxorubicin—prostate cancer	8.93e-05	0.000674	CcSEcCtD
Pseudoephedrine—Anorexia—Epirubicin—prostate cancer	8.85e-05	0.000668	CcSEcCtD
Pseudoephedrine—Dizziness—Capecitabine—prostate cancer	8.81e-05	0.000665	CcSEcCtD
Pseudoephedrine—Vomiting—Docetaxel—prostate cancer	8.75e-05	0.00066	CcSEcCtD
Pseudoephedrine—Rash—Docetaxel—prostate cancer	8.68e-05	0.000655	CcSEcCtD
Pseudoephedrine—Dermatitis—Docetaxel—prostate cancer	8.67e-05	0.000654	CcSEcCtD
Pseudoephedrine—Confusional state—Doxorubicin—prostate cancer	8.66e-05	0.000654	CcSEcCtD
Pseudoephedrine—Headache—Docetaxel—prostate cancer	8.62e-05	0.000651	CcSEcCtD
Pseudoephedrine—Asthenia—Prednisone—prostate cancer	8.52e-05	0.000643	CcSEcCtD
Pseudoephedrine—Vomiting—Capecitabine—prostate cancer	8.47e-05	0.000639	CcSEcCtD
Pseudoephedrine—Rash—Capecitabine—prostate cancer	8.4e-05	0.000634	CcSEcCtD
Pseudoephedrine—Insomnia—Epirubicin—prostate cancer	8.4e-05	0.000634	CcSEcCtD
Pseudoephedrine—Dermatitis—Capecitabine—prostate cancer	8.4e-05	0.000633	CcSEcCtD
Pseudoephedrine—Tachycardia—Doxorubicin—prostate cancer	8.38e-05	0.000633	CcSEcCtD
Pseudoephedrine—Headache—Capecitabine—prostate cancer	8.35e-05	0.00063	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Doxorubicin—prostate cancer	8.3e-05	0.000627	CcSEcCtD
Pseudoephedrine—Dyspnoea—Epirubicin—prostate cancer	8.28e-05	0.000625	CcSEcCtD
Pseudoephedrine—Anorexia—Doxorubicin—prostate cancer	8.19e-05	0.000618	CcSEcCtD
Pseudoephedrine—Nausea—Docetaxel—prostate cancer	8.18e-05	0.000617	CcSEcCtD
Pseudoephedrine—Dyspepsia—Epirubicin—prostate cancer	8.17e-05	0.000617	CcSEcCtD
Pseudoephedrine—Decreased appetite—Epirubicin—prostate cancer	8.07e-05	0.000609	CcSEcCtD
Pseudoephedrine—Pain—Epirubicin—prostate cancer	7.94e-05	0.000599	CcSEcCtD
Pseudoephedrine—Nausea—Capecitabine—prostate cancer	7.92e-05	0.000597	CcSEcCtD
Pseudoephedrine—Dizziness—Prednisone—prostate cancer	7.85e-05	0.000592	CcSEcCtD
Pseudoephedrine—Insomnia—Doxorubicin—prostate cancer	7.77e-05	0.000586	CcSEcCtD
Pseudoephedrine—Dyspnoea—Doxorubicin—prostate cancer	7.66e-05	0.000578	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Epirubicin—prostate cancer	7.65e-05	0.000577	CcSEcCtD
Pseudoephedrine—Atomoxetine—CYP3A4—prostate cancer	7.6e-05	0.0221	CrCbGaD
Pseudoephedrine—Dyspepsia—Doxorubicin—prostate cancer	7.56e-05	0.000571	CcSEcCtD
Pseudoephedrine—Vomiting—Prednisone—prostate cancer	7.55e-05	0.00057	CcSEcCtD
Pseudoephedrine—Rash—Prednisone—prostate cancer	7.48e-05	0.000565	CcSEcCtD
Pseudoephedrine—Dermatitis—Prednisone—prostate cancer	7.48e-05	0.000564	CcSEcCtD
Pseudoephedrine—Decreased appetite—Doxorubicin—prostate cancer	7.47e-05	0.000563	CcSEcCtD
Pseudoephedrine—Headache—Prednisone—prostate cancer	7.44e-05	0.000561	CcSEcCtD
Pseudoephedrine—Pain—Doxorubicin—prostate cancer	7.35e-05	0.000554	CcSEcCtD
Pseudoephedrine—Body temperature increased—Epirubicin—prostate cancer	7.34e-05	0.000554	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Doxorubicin—prostate cancer	7.08e-05	0.000534	CcSEcCtD
Pseudoephedrine—Nausea—Prednisone—prostate cancer	7.05e-05	0.000532	CcSEcCtD
Pseudoephedrine—Body temperature increased—Doxorubicin—prostate cancer	6.79e-05	0.000512	CcSEcCtD
Pseudoephedrine—Asthenia—Epirubicin—prostate cancer	6.66e-05	0.000503	CcSEcCtD
Pseudoephedrine—Asthenia—Doxorubicin—prostate cancer	6.16e-05	0.000465	CcSEcCtD
Pseudoephedrine—Dizziness—Epirubicin—prostate cancer	6.14e-05	0.000463	CcSEcCtD
Pseudoephedrine—Vomiting—Epirubicin—prostate cancer	5.9e-05	0.000445	CcSEcCtD
Pseudoephedrine—Rash—Epirubicin—prostate cancer	5.85e-05	0.000442	CcSEcCtD
Pseudoephedrine—Dermatitis—Epirubicin—prostate cancer	5.85e-05	0.000441	CcSEcCtD
Pseudoephedrine—Headache—Epirubicin—prostate cancer	5.82e-05	0.000439	CcSEcCtD
Pseudoephedrine—Dizziness—Doxorubicin—prostate cancer	5.68e-05	0.000429	CcSEcCtD
Pseudoephedrine—Nausea—Epirubicin—prostate cancer	5.51e-05	0.000416	CcSEcCtD
Pseudoephedrine—Vomiting—Doxorubicin—prostate cancer	5.46e-05	0.000412	CcSEcCtD
Pseudoephedrine—Rash—Doxorubicin—prostate cancer	5.42e-05	0.000409	CcSEcCtD
Pseudoephedrine—Dermatitis—Doxorubicin—prostate cancer	5.41e-05	0.000408	CcSEcCtD
Pseudoephedrine—Headache—Doxorubicin—prostate cancer	5.38e-05	0.000406	CcSEcCtD
Pseudoephedrine—Nausea—Doxorubicin—prostate cancer	5.1e-05	0.000385	CcSEcCtD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB3—prostate cancer	2.63e-06	1.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGFR2—prostate cancer	2.63e-06	1.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APC—prostate cancer	2.63e-06	1.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	2.63e-06	1.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LPL—prostate cancer	2.61e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGF—prostate cancer	2.6e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IRS1—prostate cancer	2.6e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CAV1—prostate cancer	2.59e-06	1.3e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.59e-06	1.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—prostate cancer	2.59e-06	1.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDGFRB—prostate cancer	2.59e-06	1.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APC—prostate cancer	2.57e-06	1.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	2.57e-06	1.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CB—prostate cancer	2.56e-06	1.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGF—prostate cancer	2.54e-06	1.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IRS1—prostate cancer	2.54e-06	1.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—prostate cancer	2.53e-06	1.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TERT—prostate cancer	2.52e-06	1.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ITGB3—prostate cancer	2.52e-06	1.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GSK3B—prostate cancer	2.52e-06	1.27e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GGT1—prostate cancer	2.51e-06	1.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—INS—prostate cancer	2.49e-06	1.25e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.48e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GSK3B—prostate cancer	2.47e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—prostate cancer	2.46e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB3—prostate cancer	2.45e-06	1.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGFR2—prostate cancer	2.44e-06	1.23e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.44e-06	1.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CREBBP—prostate cancer	2.44e-06	1.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—INS—prostate cancer	2.43e-06	1.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HIF1A—prostate cancer	2.41e-06	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—prostate cancer	2.41e-06	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—prostate cancer	2.4e-06	1.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CREBBP—prostate cancer	2.38e-06	1.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CG—prostate cancer	2.36e-06	1.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—prostate cancer	2.36e-06	1.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—prostate cancer	2.35e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—prostate cancer	2.35e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—RXRA—prostate cancer	2.35e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TERT—prostate cancer	2.35e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—prostate cancer	2.34e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTEN—prostate cancer	2.34e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CAV1—prostate cancer	2.34e-06	1.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	2.33e-06	1.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	2.31e-06	1.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KDR—prostate cancer	2.31e-06	1.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	2.29e-06	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	2.29e-06	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	2.28e-06	1.14e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—COMT—prostate cancer	2.27e-06	1.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—KRAS—prostate cancer	2.26e-06	1.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	2.26e-06	1.14e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTP1—prostate cancer	2.26e-06	1.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ESR1—prostate cancer	2.25e-06	1.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HIF1A—prostate cancer	2.24e-06	1.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	2.24e-06	1.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—INS—prostate cancer	2.24e-06	1.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	2.24e-06	1.12e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—EP300—prostate cancer	2.23e-06	1.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—prostate cancer	2.22e-06	1.12e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ITPR1—prostate cancer	2.22e-06	1.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—KRAS—prostate cancer	2.21e-06	1.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF2—prostate cancer	2.21e-06	1.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BAD—prostate cancer	2.2e-06	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CREBBP—prostate cancer	2.19e-06	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—prostate cancer	2.19e-06	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOS3—prostate cancer	2.18e-06	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CAV1—prostate cancer	2.17e-06	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF2—prostate cancer	2.16e-06	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KDR—prostate cancer	2.15e-06	1.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOS3—prostate cancer	2.13e-06	1.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CG—prostate cancer	2.13e-06	1.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APC—prostate cancer	2.13e-06	1.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—JAK2—prostate cancer	2.12e-06	1.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGF—prostate cancer	2.1e-06	1.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IRS1—prostate cancer	2.1e-06	1.06e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TYMS—prostate cancer	2.1e-06	1.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ESR1—prostate cancer	2.09e-06	1.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	2.08e-06	1.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CD—prostate cancer	2.08e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—JAK2—prostate cancer	2.07e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.07e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MDM2—prostate cancer	2.07e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB2—prostate cancer	2.04e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GSK3B—prostate cancer	2.04e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BAD—prostate cancer	2.04e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—LPL—prostate cancer	2.04e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	2.03e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MDM2—prostate cancer	2.03e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	2.01e-06	1.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—INS—prostate cancer	2.01e-06	1.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB2—prostate cancer	2e-06	1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APC—prostate cancer	1.98e-06	9.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CG—prostate cancer	1.98e-06	9.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CREBBP—prostate cancer	1.97e-06	9.92e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	1.97e-06	9.91e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.97e-06	9.89e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NOS3—prostate cancer	1.96e-06	9.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IRS1—prostate cancer	1.95e-06	9.82e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGF—prostate cancer	1.95e-06	9.82e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.95e-06	9.81e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—prostate cancer	1.95e-06	9.79e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—prostate cancer	1.94e-06	9.75e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—prostate cancer	1.94e-06	9.74e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GSK3B—prostate cancer	1.9e-06	9.54e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—prostate cancer	1.89e-06	9.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	1.89e-06	9.51e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAP2K1—prostate cancer	1.88e-06	9.47e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—INS—prostate cancer	1.87e-06	9.41e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	1.87e-06	9.4e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CD—prostate cancer	1.87e-06	9.4e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CASP3—prostate cancer	1.85e-06	9.32e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—prostate cancer	1.85e-06	9.31e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—prostate cancer	1.85e-06	9.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SERPINE1—prostate cancer	1.85e-06	9.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	1.85e-06	9.3e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—prostate cancer	1.84e-06	9.26e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.83e-06	9.22e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CREBBP—prostate cancer	1.83e-06	9.22e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—KRAS—prostate cancer	1.83e-06	9.21e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	1.83e-06	9.2e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CASP3—prostate cancer	1.81e-06	9.11e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CB—prostate cancer	1.81e-06	9.11e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—prostate cancer	1.81e-06	9.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—prostate cancer	1.81e-06	9.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCND1—prostate cancer	1.8e-06	9.07e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—prostate cancer	1.8e-06	9.06e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—prostate cancer	1.8e-06	9.06e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARA—prostate cancer	1.8e-06	9.04e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—prostate cancer	1.79e-06	9.02e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF2—prostate cancer	1.79e-06	9e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	1.79e-06	8.98e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOS3—prostate cancer	1.77e-06	8.88e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCND1—prostate cancer	1.76e-06	8.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—prostate cancer	1.75e-06	8.81e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAP2K1—prostate cancer	1.75e-06	8.8e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	1.75e-06	8.79e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	1.74e-06	8.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTEN—prostate cancer	1.74e-06	8.75e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CD—prostate cancer	1.74e-06	8.74e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3CA—prostate cancer	1.72e-06	8.65e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SERPINE1—prostate cancer	1.72e-06	8.64e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JAK2—prostate cancer	1.72e-06	8.63e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—prostate cancer	1.71e-06	8.61e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	1.71e-06	8.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTEN—prostate cancer	1.7e-06	8.56e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—KRAS—prostate cancer	1.7e-06	8.55e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—prostate cancer	1.7e-06	8.54e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAV1—prostate cancer	1.69e-06	8.5e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	1.68e-06	8.46e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MDM2—prostate cancer	1.68e-06	8.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF2—prostate cancer	1.66e-06	8.37e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—prostate cancer	1.66e-06	8.35e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EP300—prostate cancer	1.66e-06	8.35e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3CA—prostate cancer	1.65e-06	8.31e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	1.65e-06	8.31e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOS3—prostate cancer	1.64e-06	8.25e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	1.63e-06	8.2e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EP300—prostate cancer	1.62e-06	8.17e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SRC—prostate cancer	1.61e-06	8.12e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JAK2—prostate cancer	1.59e-06	8.02e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SRC—prostate cancer	1.58e-06	7.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—prostate cancer	1.57e-06	7.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	1.57e-06	7.88e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTEN—prostate cancer	1.57e-06	7.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	1.56e-06	7.86e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT3—prostate cancer	1.56e-06	7.83e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MDM2—prostate cancer	1.56e-06	7.83e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.54e-06	7.75e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—prostate cancer	1.54e-06	7.73e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	1.53e-06	7.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	1.53e-06	7.69e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT3—prostate cancer	1.52e-06	7.66e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	1.51e-06	7.62e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	1.51e-06	7.61e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CASP3—prostate cancer	1.5e-06	7.54e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—prostate cancer	1.5e-06	7.53e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—EP300—prostate cancer	1.49e-06	7.51e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—prostate cancer	1.49e-06	7.49e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCND1—prostate cancer	1.46e-06	7.34e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—INS—prostate cancer	1.46e-06	7.33e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	1.46e-06	7.32e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—prostate cancer	1.45e-06	7.27e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	1.45e-06	7.27e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—prostate cancer	1.44e-06	7.26e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.43e-06	7.18e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.42e-06	7.15e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.42e-06	7.12e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—prostate cancer	1.42e-06	7.12e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—prostate cancer	1.41e-06	7.12e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.41e-06	7.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—prostate cancer	1.41e-06	7.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.41e-06	7.08e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.41e-06	7.07e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.39e-06	7e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.39e-06	6.99e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—prostate cancer	1.38e-06	6.96e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.38e-06	6.96e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.37e-06	6.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.36e-06	6.82e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.35e-06	6.81e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—prostate cancer	1.35e-06	6.79e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.34e-06	6.75e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.34e-06	6.75e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KRAS—prostate cancer	1.34e-06	6.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.32e-06	6.62e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.31e-06	6.6e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.31e-06	6.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KRAS—prostate cancer	1.31e-06	6.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.31e-06	6.57e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NOS3—prostate cancer	1.28e-06	6.43e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.28e-06	6.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.27e-06	6.4e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.26e-06	6.33e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.25e-06	6.28e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	1.23e-06	6.18e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.21e-06	6.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	1.2e-06	6.04e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—prostate cancer	1.19e-06	5.97e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.18e-06	5.94e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.18e-06	5.94e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.17e-06	5.89e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.17e-06	5.89e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.17e-06	5.88e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.17e-06	5.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—prostate cancer	1.16e-06	5.84e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	1.14e-06	5.76e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CA—prostate cancer	1.1e-06	5.55e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—prostate cancer	1.09e-06	5.47e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—prostate cancer	1.09e-06	5.47e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	1.08e-06	5.46e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	1.08e-06	5.44e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—prostate cancer	1.06e-06	5.35e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	1.06e-06	5.35e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTEN—prostate cancer	1.02e-06	5.13e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	1e-06	5.05e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—prostate cancer	1e-06	5.04e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	9.94e-07	5e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—prostate cancer	9.81e-07	4.94e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—EP300—prostate cancer	9.73e-07	4.89e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—prostate cancer	9.61e-07	4.83e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	9.23e-07	4.64e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—prostate cancer	9.02e-07	4.54e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—prostate cancer	8.93e-07	4.49e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—prostate cancer	8.8e-07	4.42e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—prostate cancer	8.17e-07	4.11e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	8.12e-07	4.08e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	7.54e-07	3.79e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.19e-07	3.62e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—prostate cancer	5.88e-07	2.96e-06	CbGpPWpGaD
